info

Yes No
Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
한국 사이트에서 영어 글로벌 무디스 사이트로 리디렉트 됩니다. 계속하시겠습니까?
메시지를 다시 보이지 않기
예
아니오

검색 조건:

  • 지역

Go

입력하신 검색어:

범위 지정:

관련 정보

주요 연락처

이벤트 일정

관련 Product

의료 서비스 제공업체 - 유럽, 중동 & 아프리카

하이라이트
리서치
발행사
해당 Rating Activity 및 Watchlist 를 보시려면 검색 범위를 지정하십시오.
모두 보기
  일자문서 유형 제목 발행사
25 Apr 2024 Credit Opinion Landesbank Hessen-Thueringen Girozentrale: Update following upgrade of ratings Landesbank Hessen-Thueringen Girozentrale
24 Apr 2024 Sector In-Depth Healthcare Providers – Global: 2023 Cyber Survey shows strong healthcare defenses but ongoing investment needed
26 Mar 2024 Rating Action Moody's upgrades BP to A1, outlook stable Amoco Productio...
Atlantic Richfi...
BP Amoco Chemic...
BP Capital Mark...
BP Capital Mark...
BP Capital Mark...
BP Corporation ...
BP Exploration ...
BP p.l.c.
BP Products Nor...
...
11 Mar 2024 Sector In-Depth Pharmaceuticals and Healthcare – Global: Pharmaceutical and medical devices companies will gain most from AI rollout
01 Mar 2024 Rating Action Moody's affirms Carnival Corporation's B2 corporate family rating, changes outlook to positive Carnival Corpor...
Carnival Holdin...
Carnival plc
Long Beach (Cit...
01 Feb 2024 Rating Methodology-Cross Sectr Hybrid Equity Credit methodology
 The document has been translated in other languages
01 Feb 2024 Rating Methodology-Cross Sectr Financial Statement Adjustments in the Analysis of Nonfinancial Corporations methodology
 The document has been translated in other languages
01 Feb 2024 Methodology Announcement Moody's updates its methodology for hybrid equity credit
 The document has been translated in other languages
01 Feb 2024 Request for Comment - Results Hybrid Equity Credit, Financial Statement Adjustments and REITs: Proposed Methodology Updates
31 Jan 2024 Sector In-Depth Pharmaceuticals and Healthcare – Europe: Developments to watch in 2024: New drugs, M&A and margin recovery
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry

    Moody's Integrity Hotline

    Via the Internet: 
    https://Moodys.ethicspoint.com
    By telephone from the United States: 
    Dial 1-866-330-MDYS (1-866-330-6397)
    By telephone from outside the United States:  
    
Dial the AT&T Direct Dial Access® code for your location.

Then, at the prompt, dial 866-330-MDYS (866-330-6397).
    홈리서치 & 등급상품 및 솔루션뉴스 & 이벤트커리어
    지원연락처고객불만 접수
    이용약관사생활보호 정책소유권
    © 2024 Moody's Investors Service, Inc., Moody’s Analytics, Inc. and/or their affiliates and licensors. All rights reserved.